Komori
Otsuka Holdings (4578) · RiskMitigated

Sluggish sales of specialty chemicals due to semiconductor market stagnation and delayed recovery in the Chinese market

First written in FY2023-Q3. 3 of 6 entries say "Mitigated", first in FY2024-H1. Latest entry: FY2026-H1.

6entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023-Q3 – FY2023MitigatedFY2024-H1 – FY2026-H12023: 120232024: 320242025: 120252026: 12026
Same theme, other companies

3 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1MitigatedAnnual report

    「The specialty chemicals segment posted higher revenue, as shipments for the automotive and electronics industries, mainly in global markets, remained firm.」

    Conditions changed from weak sales due to the stagnant semiconductor market and delayed recovery in China, as reported through the previous period, to higher revenue driven by firm shipments for the automotive and electronics industries.
  2. FY2024MitigatedAnnual report

    「The specialty chemicals segment posted higher revenue, mainly due to the recovery of the automotive and smartphone markets.」

    Conditions changed from weak sales in the previous period due to the stagnant semiconductor market and delayed recovery in China to higher revenue driven by the recovery of the automotive and smartphone markets.
  3. FY2024-H1MitigatedAnnual report

    「The specialty chemicals segment posted higher revenue, mainly due to the recovery of the automotive and smartphone markets.」

    In the current interim consolidated accounting period, revenue in the specialty chemicals segment increased on the recovery of the automotive and smartphone markets, compared with the weak sales reported in the previous period due to the stagnant semiconductor market and delayed recovery in China.
  4. FY2024-Q1WorsenedAnnual report

    「Revenue in the specialty chemicals segment declined due to lower prices for basic chemicals resulting from excess inventories in China.」

    Excess inventories in China materialized as lower prices for basic chemicals and lower revenue in the specialty chemicals segment.
  5. FY2023RestatedAnnual report

    「Revenue in the specialty chemicals segment remained at approximately the previous fiscal year's level, despite the delayed recovery in the semiconductor market and the stagnation of the Chinese market.」

    The delayed recovery in the semiconductor market and continued stagnation in China are affecting the sales environment for the specialty chemicals segment.
  6. FY2023-Q3First statedAnnual report

    「Revenue in the specialty chemicals segment declined slightly, as sales of chemicals for the semiconductor industry remained weak due to the stagnant semiconductor market, particularly the delayed recovery in China.」

    The stagnant semiconductor market and delayed recovery in China materialized as weak sales of chemicals for the semiconductor industry and lower revenue in the specialty chemicals segment.
Moved together

"Pipeline Progress in Clinical Development, Regulatory Approval and Commercialization" moved the same way as this thread, in the same document, in 3 of its 6 moves.

333322★123456
  1. ★This thread
  2. 1Pipeline Progress in Clinical Development, Regulatory Approval and Commercialization3×
  3. 2Investment Plan for Research and Production Facilities3×
  4. 3Improving Capital Efficiency and Ensuring Financial Soundness3×
  5. 4Building the Three Core Brands into ¥100 Billion Brands and Developing the Three Growth Brands3×
  6. 5Continued investment in research and development2×
  7. 6Expansion of Overseas Sales of Pharmaceutical and Health-Related Products2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Otsuka Holdings's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Sluggish sales of specialty chemicals due to semiconductor market stagnation and delayed recovery in the Chinese market | Otsuka Holdings Co.,Ltd. (4578) | Komori